In ₹ Crore except Per Share Latest Annual | YATHARTH FY26 | MAXHEALTH FY26 | MEDANTA FY26 | FORTIS FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | ◆ 53.91× | 69.66× | 70.35× | 65.36× | 69.66× -23% | |
| P/B | ◆ 5.23× | 9.36× | 9.83× | 6.70× | 9.36× -44% | |
| EV/EBITDA | ◆ 32.47× | 46.08× | 43.75× | 33.84× | 43.75× -26% | |
| Market Cap | ₹9,453 Cr | ₹1.01L Cr | ₹39,148 Cr | ₹68,097 Cr | ₹68,097 Cr -86% | |
| Growth | ||||||
| Revenue CAGR 3Y | ◆ 48.11% | 22.43% | 17.85% | 13.17% | 17.85% +170% | |
| Revenue CAGR 5Y | — | ◆ 27.30% | — | 17.76% | 22.53% | |
| Net Income CAGR 3Y | ◆ 38.45% | 9.34% | 19.33% | 18.91% | 18.91% +103% | |
| Revenue YoY (latest Q) | ◆ 52.33% | 16.70% | 26.50% | 17.46% | 17.46% +200% | |
| Net Income YoY (latest Q) | ◆ 8.05% | 4.87% | -1.09% | 2.26% | 2.26% +256% | |
| Profitability | ||||||
| EBITDA Margin | 24.20% | ◆ 26.79% | 20.84% | 22.84% | 22.84% +6% | |
| Net Income Margin | 14.11% | ◆ 17.23% | 12.56% | 11.66% | 12.56% +12% | |
| Return on Common Equity | 9.42% | 13.42% | ◆ 13.97% | 10.25% | 13.42% -30% | |
| Return on Capital Employed | 9.74% | 11.94% | ◆ 13.20% | 11.81% | 11.94% -18% | |
| Return on Assets | 7.46% | 8.37% | ◆ 9.38% | 6.67% | 8.37% -11% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.14× | 0.32× | 0.30× | 0.28× | 0.30× -53% | |
| Interest Coverage | ◆ 31.26× | 7.64× | 8.80× | 5.20× | 7.64× +309% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹1,207 Cr | ₹8,373 Cr | ₹4,410 Cr | ₹9,128 Cr | ₹8,373 Cr -86% | |
| Net Income | ₹170 Cr | ₹1,442 Cr | ₹554 Cr | ₹1,064 Cr | ₹1,064 Cr -84% | |
| Total Assets | ₹2,282 Cr | ₹17,231 Cr | ₹5,905 Cr | ₹15,966 Cr | ₹15,966 Cr -86% | |
| EPS | ₹18.2 | ₹14.83 | ₹20.71 | ₹13.8 | ₹14.83 +23% | |
| Book Value per Share | ₹187.55 | ₹110.43 | ₹148.29 | ₹134.69 | ₹134.69 +39% | |